|
AU2020103779A4
|
|
Covid-19 classification recognition method based on ct images of lungs
|
|
AU2020103782A4
|
|
Pet/ct high-dimensional feature level selection method based on genetic algorithm and variable precision rough set
|
|
AU2020103785A4
|
|
Method for improving recognition rates of mri images of prostate tumors based on cad system
|
|
AU2020103731A4
|
|
Two-modal medical image fusion method for improving credibility of image evaluation results
|
|
CN112198262A
|
|
Method for detecting non-steroidal anti-inflammatory drugs in water sample
|
|
CN112263573A
|
|
Application of amentoflavone in preparation of medicine for treating glioma
|
|
CN112057464A
|
|
Application of ginsenoside Rg3 combined with GP
|
|
CN112143750A
|
|
M-cell-targeted recombinant lactobacillus surface display system, recombinant lactobacillus vaccine, preparation method and application
|
|
CN112190704A
|
|
M cell targeting recombinant lactobacillus vaccine, preparation method and application
|
|
CN112138154A
|
|
Helicobacter pylori tetravalent adhesion factor GEM particle vaccine, preparation method and application
|
|
CN112107682A
|
|
M cell targeting recombinant lactobacillus vaccine, preparation method and application
|
|
CN112190703A
|
|
GEM particle surface display system of targeting M cells, particle vaccine, preparation method and application
|
|
CN112159842A
|
|
Molecular marker for early warning of atherosclerosis and application thereof
|
|
CN112156231A
|
|
Olfactory ensheathing cell-hyaluronic acid hydrogel composite material and preparation method thereof
|
|
CN112108120A
|
|
Magnetic layered double hydroxide-metal organic framework composite material and preparation method and application thereof
|
|
CN111700890A
|
|
Application of hesperetin as TGF-beta 1 signal inhibitor
|
|
CN112075498A
|
|
Anti-fatigue composition preparation containing medlar and preparation method and application thereof
|
|
CN112075621A
|
|
Composition with blood fat auxiliary regulation function and preparation method and application thereof
|
|
CN111888357A
|
|
Chemotherapy drug-co-loaded crizotinib prodrug polymer micelle and preparation method thereof
|
|
CN111763263A
|
|
Preparation method and detection kit of clostridium difficile antigen and polyclonal antibody
|
